Your browser doesn't support javascript.
loading
Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes - Data from a randomized, placebo-controlled study.
Rau, Matthias; Thiele, Kirsten; Hartmann, Niels-Ulrik Korbinian; Möllmann, Julia; Wied, Stephanie; Hohl, Mathias; Marx, Nikolaus; Lehrke, Michael.
Affiliation
  • Rau M; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Thiele K; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Hartmann NK; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Möllmann J; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Wied S; Department of Medical Statistics, RWTH Aachen University, Aachen, Germany.
  • Hohl M; Department of Internal Medicine III, University Hospital Saarland, Saarland University, Homburg/Saar, Germany.
  • Marx N; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Lehrke M; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
Bone Rep ; 16: 101175, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35242892
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Bone Rep Year: 2022 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Bone Rep Year: 2022 Document type: Article Affiliation country: Germany